ArticleBMC cancer2026
Patient preference for first-line treatments of ALK-positive metastatic non-small cell lung cancer: a discrete choice experiment.
Jiachen Shao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it